Survival and glycemic control in patients with coexisting melanoma and diabetes mellitus
Author(s) -
Nina J. Karlin,
Aaron R. Mangold,
Shailja B Amin,
Heidi E. Kosiorek,
Matthew Buras,
Patricia M Verona,
Curtiss B. Cook
Publication year - 2019
Publication title -
future science oa
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.825
H-Index - 23
ISSN - 2056-5623
DOI - 10.4155/fsoa-2018-0084
Subject(s) - medicine , glycemic , melanoma , diabetes mellitus , oncology , survival analysis , overall survival , gastroenterology , endocrinology , cancer research
Melanoma did not adversely impact glycemic control. The DM did not adversely impact survival of patients with melanoma, although increased PFS for melanoma was seen in individuals with DM.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom